170
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Zoledronate and Molecular Iodine Cause Synergistic Cell Death in Triple Negative Breast Cancer through Endoplasmic Reticulum Stress

, , , , , , , & show all
Pages 679-688 | Received 22 Apr 2015, Accepted 19 Jan 2016, Published online: 26 Apr 2016

References

  • Aceves C, Anguiano B, and Delgado G: Is iodine a gatekeeper of the integrity of the mammary gland? J Mammary Gland Biol Neoplasia 10, 189–196, 2005.
  • Aceves C, Anguiano B, and Delgado G: The extrathyronine actions of iodine as antioxidant, apoptotic, and differentiation factor in various tissues. Thyroid 23, 938–946, 2013.
  • Rosner H, Torremante P, Moller W, and Gartner R: Antiproliferative/cytotoxic activity of molecular iodine and iodolactones in various human carcinoma cell lines. No interfering with EGF-signaling, but evidence for apoptosis. Exp Clin Endocrinol Diabetes 118, 410–419, 2010.
  • Venturi S: Is there a role for iodine in breast diseases? Breast 10, 379–382, 2001.
  • Funahashi H, Imai T, Tanaka Y, Tsukamura K, Hayakawa Y, et al.: Wakame seaweed suppresses the proliferation of 7,12-dimethylbenz(a)-anthracene-induced mammary tumors in rats. Jpn J Cancer Res 90, 922–927, 1999.
  • Garcia-Solis P, Alfaro Y, Anguiano B, Delgado G, Guzman RC, et al.: Inhibition of N-methyl-N-nitrosourea-induced mammary carcinogenesis by molecular iodine (I2) but not by iodide (I-) treatment Evidence that I2 prevents cancer promotion. Mol Cell Endocrinol 236, 49–57, 2005.
  • Stoddard FR, 2nd, Brooks AD, Eskin BA, and Johannes GJ: Iodine alters gene expression in the MCF7 breast cancer cell line: evidence for an anti-estrogen effect of iodine. Int J Med Sci 5, 189–196, 2008.
  • Gartner R, Rank P, and Ander B: The role of iodine and delta-iodolactone in growth and apoptosis of malignant thyroid epithelial cells and breast cancer cells. Hormones (Athens) 9, 60–66, 2010.
  • Arroyo-Helguera O, Anguiano B, Delgado G, and Aceves C: Uptake and antiproliferative effect of molecular iodine in the MCF-7 breast cancer cell line. Endocr Relat Cancer 13, 1147–1158, 2006.
  • Shrivastava A, Tiwari M, Sinha RA, Kumar A, Balapure AK, et al: Molecular iodine induces caspase-independent apoptosis in human breast carcinoma cells involving the mitochondria-mediated pathway. J Biol Chem 281, 19762–19771, 2006.
  • Alfaro Y, Delgado G, Carabez A, Anguiano B, and Aceves C: Iodine and doxorubicin, a good combination for mammary cancer treatment: antineoplastic adjuvancy, chemoresistance inhibition, and cardioprotection. Mol Cancer 12, 45, 2013.
  • Singh P, Godbole M, Rao G, Annarao S, Mitra K, et al: Inhibition of autophagy stimulate molecular iodine-induced apoptosis in hormone independent breast tumors. Biochem Biophys Res Commun 415, 181–186, 2011.
  • Daubine F, Le Gall C, Gasser J, Green J, and Clezardin P: Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis. J Natl Cancer Inst 99, 322–330, 2007.
  • Verdijk R, Franke HR, Wolbers F, and Vermes I: Differential effects of bisphosphonates on breast cancer cell lines. Cancer Lett 246, 308–312, 2007.
  • Okada C, and Rechsteiner YM: Introduction of macromolecules into cultured mammalian cells by osmotic lysis of pinocytic vesicles. Cell 29, 33–41, 1982.
  • Ma YG, Liu WC, Dong S, Du C, Wang XJ, et al: Activation of BK(Ca) channels in zoledronic acid-induced apoptosis of MDA-MB-231 breast cancer cells. PLoS One 7, e37451, 2012.
  • Roger S, Potier M, Vandier C, Le Guennec JY, and Besson P: Description and role in proliferation of iberiotoxin-sensitive currents in different human mammary epithelial normal and cancerous cells. Biochim Biophys Acta 1667, 190–199, 2004.
  • Song SD, Zhou J, Zhao H, Cen JN, and Li DC: MicroRNA-375 targets the 3-phosphoinositide-dependent protein kinase-1 gene in pancreatic carcinoma. Oncol Lett 6, 953–959, 2013.
  • Liang X, Tang J, Liang Y, Jin R, and Cai X: Suppression of autophagy by chloroquine sensitizes 5-fluorouracil-mediated cell death in gallbladder carcinoma cells. Cell Biosci 4, 10, 2014.
  • Lan YC, Chang CL, Sung MT, Yin PH, Hsu CC, et al: Zoledronic acid-induced cytotoxicity through endoplasmic reticulum stress triggered REDD1-mTOR pathway in breast cancer cells. Anticancer Res 33, 3807–3814, 2013.
  • Russell RG, Watts NB, Ebetino FH, and Rogers MJ: Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int 19, 733–759, 2008.
  • Shuda M, Kondoh N, Imazeki N, Tanaka K, Okada T, et al: Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis. J Hepatol 38, 605–614, 2003.
  • Verfaillie T, Salazar M, Velasco G, and Agostinis P: Linking ER stress to autophagy: potential implications for cancer therapy. Int J Cell Biol 930509, 2010.
  • Schonthal AH: Endoplasmic reticulum stress: its role in disease and novel prospects for therapy. Scientifica (Cairo) 857516, 2012.
  • Shiraishi H, Okamoto H, Yoshimura A, and Yoshida H: ER stress-induced apoptosis and caspase-12 activation occurs downstream of mitochondrial apoptosis involving Apaf-1. J Cell Sci 119, 3958–3966, 2006.
  • Zhu Y, Men R, Wen M, Hu X, Liu X, and Yang L: Blockage of TRPM7 channel induces hepatic stellate cell death through endoplasmic reticulum stress-mediated apoptosis. Life Sci 94, 37–44, 2014.
  • Eskin BA, Shuman R, Krouse T, and Merion JA: Rat mammary gland atypia produced by iodine blockade with perchlorate. Cancer Res 35, 2332–2339, 1975.
  • Eskin BA, Grotkowski CE, Connolly CP, and Ghent WR: Different tissue responses for iodine and iodide in rat thyroid and mammary glands. Biol Trace Elem Res 49, 9–19, 1995.
  • Ghent WR, Eskin BA, Low DA, and Hill LP: Iodine replacement in fibrocystic disease of the breast. Can J Surg 36, 453–460, 1993.
  • Funahashi H, Imai T, Tanaka Y, Tobinaga J, Wada M, et al: Suppressive effect of iodine on DMBA-induced breast tumor growth in the rat. J Surg Oncol 61, 209–213, 1996.
  • Lacerna L, and Hohneker J: Zoledronic acid for the treatment of bone metastases in patients with breast cancer and other solid tumors. Semin Oncol 30, 150–160, 2003.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.